Article metrics

Download PDFPDF
Cost effectiveness study
Cardiac resynchronisation therapy with an implantable cardioverter defibrillator appears to be cost-effective in patients with mild heart failure

 

Online download statistics by month:

Online download statistics by month: February 2016 to December 2022

AbstractFullPdf
Feb 20164942
Mar 20164984
Apr 20166810
May 2016297510
Jun 2016180319
Jul 2016133713
Aug 20164214
Sep 201637019
Oct 20162422
Nov 20162654
Dec 201668126
Jan 20174026
Feb 2017813
Mar 20171301
Apr 20171844
May 20171921
Jun 20171653
Jul 20173300
Aug 20173232
Sep 20172310
Oct 20173900
Nov 20174233
Dec 20171800
Jan 20182700
Feb 20183722
Mar 20184020
Apr 20183842
May 20183222
Jun 20184200
Jul 20183822
Aug 20184100
Sep 20183200
Oct 20183700
Nov 20183001
Dec 20185910
Jan 20194111
Feb 20193942
Mar 20193710
Apr 20194200
May 20193125
Jun 20192000
Jul 20192020
Aug 20192310
Sep 20192800
Oct 20193000
Nov 20192602
Dec 20191310
Jan 20201600
Feb 20201913
Mar 20201222
Apr 2020300
May 20201621
Jun 20201500
Jul 20203041
Aug 20201110
Sep 20202300
Oct 20202200
Nov 20201300
Dec 20201730
Jan 20211910
Feb 20211800
Mar 20211712
Apr 2021900
May 2021421
Jun 2021112
Sep 2021111
Oct 20211510
Nov 20212200
Dec 20212500
Jan 20221910
Feb 20221600
Mar 20222000
Apr 20222700
May 20225200
Jun 20224200
Jul 20222115
Aug 20227225
Sep 20223300
Oct 20223400
Nov 20221800
Dec 20221100
Total2770107168